K Number
K211155
Device Name
Auto CPAP System
Date Cleared
2022-03-09

(324 days)

Product Code
Regulation Number
868.5905
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Auto CPAP System is a CPAP (Continuous Positive Airway Pressure) device designed for the treatment of adult Obstructive Sleep Apnea (OSA) only, either in the hospital or at home. Auto CPAP System is for prescription use only. It is a travel CPAP device intended for single-patient use. LightTrip App is a mobile application for patients to remotely operate BMC Mini serial devices, and transmit, store and display usage and treatment information. It can also receive parameters and device firmware upgrade data from the cloud, and then transmit these data to the device. The LightTrip app also allows healthcare professionals to remotely configure compatible OSA therapy devices. LightTrip App is for prescription use only.
Device Description
Auto CPAP System is a microprocessor controlled, blower-based system that generates continuous positive airway pressure (CPAP) to support treatment of obstructive sleep apnea. The system provides fixed or auto-adjust pressure from 4 to 20 cmH2O above the ambient atmospheric pressure to a patient's oral/nasal airway. The Auto CPAP System is designed and developed on the basis of the predicate device Luna CPAP and Auto CPAP System (K153387). The parameters and algorithms of the two devices, such as the treatment mode (CPAP and AutoCPAP), the pressure range (4 to 20 cm H2O), and the Respiratory Event Detection, are consistent. Compared with the predicate device, the subject device does not include a humidifier and an LCD screen. The parameters of subject device are displayed and set via the LightTrip App.
More Information

Luna CPAP and Auto CPAP System (K153387), Menai System (K160836)

No
The summary describes a standard CPAP device with a mobile app for control and data display. There is no mention of AI or ML algorithms for pressure adjustment, event detection, or any other function. The "AutoCPAP" mode likely refers to a traditional algorithm for pressure adjustment based on detected events, not an AI/ML approach.

Yes
The device is designed for the treatment of adult Obstructive Sleep Apnea (OSA) by generating continuous positive airway pressure, which directly addresses a medical condition.

No

This device is a CPAP system designed for the treatment of Obstructive Sleep Apnea, not for its diagnosis. While it mentions "Respiratory Event Detection" (consistent with its predicate), its primary function is to deliver positive airway pressure for therapy.

No

The device description clearly states it is a "microprocessor controlled, blower-based system that generates continuous positive airway pressure (CPAP)". This indicates the presence of hardware components beyond just software. While the LightTrip App is software, the Auto CPAP System itself is a hardware device with integrated software.

Based on the provided information, the Auto CPAP System is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • Intended Use: The intended use is for the treatment of adult Obstructive Sleep Apnea (OSA) by providing continuous positive airway pressure to the patient's airway. This is a therapeutic intervention, not a diagnostic test performed on samples taken from the body.
  • Device Description: The device is a blower-based system that generates pressure. It does not analyze biological samples.
  • Lack of IVD Characteristics: The description does not mention any analysis of biological samples (blood, urine, tissue, etc.) or the detection of specific analytes or markers.

IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Auto CPAP System's function is to deliver air pressure for therapeutic treatment.

N/A

Intended Use / Indications for Use

Auto CPAP System is a CPAP (Continuous Positive Airway Pressure) device designed for the treatment of adult Obstructive Sleep Apnea (OSA) only, either in the hospital or at home.

Auto CPAP System is for prescription use only. It is a travel CPAP device intended for single-patient use.

LightTrip App is a mobile application for patients to remotely operate BMC Mini serial devices, and transmit, store and display usage and treatment information. It can also receive parameters and device firmware upgrade data from the cloud, and then transmit these data to the device. The LightTrip app also allows healthcare professionals to remotely configure compatible OSA therapy devices. LightTrip App is for prescription use only.

Product codes

BZD

Device Description

Auto CPAP System is a microprocessor controlled, blower-based system that generates continuous positive airway pressure (CPAP) to support treatment of obstructive sleep apnea. The system provides fixed or auto-adjust pressure from 4 to 20 cmH2O above the ambient atmospheric pressure to a patient's oral/nasal airway.
The Auto CPAP System is designed and developed on the basis of the predicate device Luna CPAP and Auto CPAP System (K153387). The parameters and algorithms of the two devices, such as the treatment mode (CPAP and AutoCPAP), the pressure range (4 to 20 cm H2O), and the Respiratory Event Detection, are consistent. Compared with the predicate device, the subject device does not include a humidifier and an LCD screen. The parameters of subject device are displayed and set via the LightTrip App.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

adult

Intended User / Care Setting

Home or hospital for patients. Healthcare professionals can remotely configure devices.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Bench Testing:

  • Maximum flow rate testing
  • Static pressure testing .
  • Dynamic pressure testing ●
  • Sound pressure level testing .
  • Display accuracy testing .

Biocompatibility Assessment:
Evaluation and testing of biocompatibility were conducted in accordance with the following standards and guidance documents:

  • · ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
  • FDA Guidance Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" June 16, 2016
  • ISO 10993-5:2009 Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-10:2010 Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization
  • · ISO 18562-1:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications Part 1: Evaluation and testing within a risk management process
  • ISO 18562-2:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications Part 2: Tests for emissions of particulate matter
  • ISO 18562-3:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications – Part 3: Tests for emissions of volatile organic compounds (VOCs)
  • ISO 18562-4:2017 Biocompatibility evaluation of breathing gas pathways in healthcare applications – Part 4: Tests for leachables in condensate

Electrical Safety and Electromagnetic Compatibility:
Electrical safety and EMC testing were conducted on the subject device Auto CPAP System. The following standards for electrical safety and EMC:

  • AAMI/ANSI ES 60601-1:2005/(R) 2012 And A1:2012. Medical Electrical Equipment - Part 1: General Requirements for Basic Safety And Essential Performance
  • IEC 60601-1-2:2014 Medical electrical equipments for basic safety and essential performance - Collateral standard: Electromagnetic disturbances Requirements and tests
  • IEC 60601-1-11:2015 Medical Electrical Equipment - Part 1-11: General Requirements for Basic Safety And Essential Performance - Collateral Standard: Requirements for Medical Electrical Equipment And Medical Electrical Systems Used In The Home Healthcare Environment
  • ISO 80601-2-70:2015 Medical electrical equipments for basic safety and essential performance of sleep apnoea breathing therapy equipment

Software Verification and Validation:
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff:

  • "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices"
  • "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices"
  • "Guidance-Radio Frequency Wireless Technology in Medical Devices"

Mechanical Testing:
Mechanical Shock Test, Sine Vibration, etc. were conducted on the tests show that there is no new safety or effectiveness question.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Luna CPAP and Auto CPAP System (K153387), Menai System (K160836)

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 868.5905 Noncontinuous ventilator (IPPB).

(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. Next to that is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

March 9, 2022

BMC Medical Co., Ltd. Amy Wang RA Room 901, Building 1, No. 28 Pingguoyuan Road Beijing, Shijingshan 100041 China

Re: K211155

Trade/Device Name: Auto CPAP System Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: Class II Product Code: BZD Dated: February 7, 2022 Received: February 7, 2022

Dear Amy Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

1

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Rachana Visaria, Ph.D. Assistant Director DHT1C: Division of Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K21155

Device Name Auto CPAP System

Indications for Use (Describe)

Auto CPAP System is a CPAP (Continuous Positive Airway Pressure) device designed for the treatment of adult Obstructive Sleep Apnea (OSA) only, either in the hospital or at home.

Auto CPAP System is for prescription use only. It is a travel CPAP device intended for single-patient use.

LightTrip App is a mobile application for patients to remotely operate BMC Mini serial devices, and transmit, store and display usage and treatment information. It can also receive parameters and device firmware upgrade data from the cloud, and then transmit these data to the device. The LightTrip app also allows healthcare professionals to remotely configure compatible OSA therapy devices. LightTrip App is for prescription use only.

Type of Use (Select one or both, as applicable)

☑ Prescription Use (Part 21 CFR 801 Subpart D)□ Over The Counter Use (21 CFR 801 Subpart C)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

Device Trade NameAuto CPAP System
ModelM1 Mini
Common/Usual NameAuto CPAP System
Date PreparedMarch 8, 2022
Sponsor IdentificationBMC Medical Co., Ltd.
Room 901, Building 1, No.28 Pingguoyuan Road,
Shijingshan, Beijing 100041, CHINA
Submission CorrespondentAmy Wang
BMC Medical Co., Ltd.
Room 901, Building 1, No.28 Pingguoyuan Road,
Shijingshan, Beijing 100041, CHINA
Phone86-18701556244
Fax86-22-82939881
Emailwangliping@bmc-medical.com
Establishment Registration #3008566132
ClassificationBMC Medical Co., Ltd.
Room 901, Building 1, No.28 Pingguoyuan Road,
Shijingshan, Beijing 100041, CHINA
ClassificationClass II Device (21 CFR 868.5905)
Classification NameNoncontinuous ventilator
Classification PanelMedical Device
Products CodeBZD
Medical SpecialtiesAnesthesiology
Predicate Device(s)Luna CPAP and Auto CPAP System (K153387)
Menai System (K160836)

4

Reason for Submission:New Device
Indications for UseAuto CPAP System is a CPAP (Continuous
Positive Airway Pressure) device designed for the treatment
of adult Obstructive Sleep Apnea (OSA) only, either in the
hospital or at home.
Auto CPAP System is for prescription use only. It is a travel
CPAP device intended for single-patient use.

LightTrip App is a mobile application for patients to
remotely operate BMC Mini serial devices, and transmit,
store and display usage and treatment information. It can also
receive parameters and device firmware upgrade data from
the cloud, and then transmit these data to the device. The
LightTrip app also allows healthcare professionals to
remotely configure compatible OSA therapy devices.
LightTrip App is for prescription use only. |
| Device Description | Auto CPAP System is a microprocessor controlled,
blower-based system that generates continuous positive
airway pressure (CPAP) to support treatment of obstructive
sleep apnea. The system provides fixed or auto-adjust
pressure from 4 to 20 cmH2O above the ambient atmospheric
pressure to a patient's oral/nasal airway.
The Auto CPAP System is designed and developed on the
basis of the predicate device Luna CPAP and Auto CPAP
System (K153387). The parameters and algorithms of the
two devices, such as the treatment mode (CPAP and
AutoCPAP), the pressure range (4 to 20 cm H2O), and the
Respiratory Event Detection, are consistent. Compared with
the predicate device, the subject device does not include a
humidifier and an LCD screen. The parameters of subject
device are displayed and set via the LightTrip App. |

Substantial Equivalence:

The subject and predicate devices have the following similarities:

  • Same Indications for Use ●
  • Similar operating principle ●
  • Similar technologies

Auto CPAP System retains similar functionality and performance features of the primary predicate device Luna CPAP and Auto CPAP System (K153387). It utilizes the same algorithm as the primary predicate device Luna CPAP and Auto CPAP System (K153387) for respiratory event detection and therapy for sleep disordered breathing events. The subject device and the primary

5

predicate device share the similar intended use, similar operating principal, and are manufactured and packaged with similar processes.

Compared with the primary predicate device, the subject device makes the following main modifications:

  • By removing the humidifier, the subject device is provided in a portable smaller footprint than the predicate for user convenience, especially for using on an aircraft or in travel. Choosing a mask with a humidifier component can improve the moisture level in the breathing air and offer relief from possible dryness.
  • The subject device includes a Bluetooth module, which enables the device to be connected with the LightTrip App on the smartphone.
  • LightTrip App is a mobile application of Auto CPAP System. The patient and the health care professional can set parameters of the device via this application. Patients can set the comfort settings, turn the device on and off using the LightTrip App. However, only health care professional is able to remotely change the prescription settings. The device can upload the running data to LightTrip App where they can be displayed, stored and uploaded to the cloud platform. LightTrip App can also obtain the remote parameter setting of the cloud platform and realize the on-line firmware upgrade of the device.

The substantial equivalence comparison is provided below.

6

Subject DevicePrimary Predicate DeviceReference Device
Auto CPAP System
(K211155)Luna® CPAP and Auto
CPAP System
(K153387)Menai System
(K160836)Comparison
Classification
Device
ClassificationClass II DeviceClass II DeviceClass II DeviceIdentical to primary
predicate
Product CodeBZDBZDBZD, MNRIdentical to primary
predicate
Classification
PanelAnesthesiologyAnesthesiologyAnesthesiologyIdentical to primary
predicate
Regulation
Number21 CFR 868.590521 CFR 868.590521 CFR 868.5905
21 CFR 868.2375Identical to primary
predicate
Regulation
NameNoncontinuous ventilatorNoncontinuous ventilatorNoncontinuous ventilatorIdentical to primary
predicate
SterileNon-sterileNon-sterileNon-sterileIdentical to primary
predicate
Intended Use and Indications for Use
Subject DevicePrimary Predicate DeviceReference Device
Auto CPAP System
(K211155)Luna® CPAP and Auto
CPAP System
(K153387)Menai System
(K160836)Comparison
Intended Use of
the DeviceAuto CPAP System is a
CPAP
(Continuous
Positive Airway Pressure)
device designed for the
treatment
of
adult
Obstructive Sleep Apnea
(OSA) only, either in the
hospital or at home.
Auto CPAP System is for
prescription use only. It is a
travel
CPAP
device
intended for single-patient
use.The Luna CPAP and Auto
CPAP System are intended to
deliver positive pressure for the
treatment of Obstructive Sleep
Apnea. The optional integrated
heated humidifier is indicated
for
the
humidification and warming of
air from the flow generator.
These devices are intended for
single
patient
use
by
prescription in the home or
hospital / institutional
environment on adult patients.The Menai self-adjusting
system is indicated for the
treatment of Obstructive
Sleep Apnea (OSA) in
patients (female patients with
mild to moderate OSA when
using AfH treatment mode)
weighing more than 66 lb (30
kg). It is intended for home
and hospital use.Similar to primary
predicate.
Intended Use of
the Software
ApplicationLightTrip App is a mobile
application for patients to
remotely operate BMC
Mini serial devices, and
transmit, store and display
usage and treatment
information. It can also
receive parameters and
device firmware upgrade
data from the cloud, and
then transmit these data to
the device. The LightTrip
app also allows healthcare
professionals to remotely
configure compatible OSA
therapy devices.
LightTrip App is for
prescription use only.N/AMonte Carlo is a mobile
application for patients to
remotely operate a prescribed
compatible ResMed machine
and transfer, analyze and
display usage and therapeutic
information. Monte Carlo also
allows healthcare
professionals to remotely
configure compatible OSA
therapy devices.Similar to the
secondary predicate.
Subject DevicePrimary Predicate DeviceSecondary Predicate Device
Auto CPAP System
(K211155)Luna® CPAP and Auto
CPAP System
(K153387)Menai System
(K160836)Comparison
Pressure Delivery
Therapy
DeliveredCPAP,
AutoCPAPCPAP,
AutoCPAPCPAP,
AutoSet,
AutoSet for Her (AfH)Identical to primary
predicate
Pressure Range4 to 20 cm H2O (in 0.5 cm
H2O increments), ≤30 cm
H2O under single fault
conditions4 to 20 cm H2O (in 0.5 cm
H2O increments), ≤ 30 cm
H2O under single fault
conditions• 4-20 cm H2O (CPAP Mode)
• 4-20 cm H2O (AutoSet
Mode)
• 4-20 cm H2O (AutoSet AfH
Mode)
• EPR +3 cm H2O (all modes)Identical to primary
predicate
Pressure
Display
Accuracy (hPa)±(0.5 hPa+4%)±(0.5 hPa+4%)±0.5 hPaIdentical to primary
predicate
Algorithm
Automatic
adjusting
CPAP
algorithmYesYesYesIdentical to primary
predicate
RampYes, the ramp time ranges
from 0 to 60 minutesYes, the ramp time ranges
from 0 to 60 minutesYes, user selected as "Off" to
45 minutes in 5 minute
incrementsIdentical to primary
predicate
Expiratory
Pressure ReliefYes,
Reslex® function
Level 1-3Yes,
Reslex® function
Level 1-3Yes,
EPR functionIdentical to primary
predicate
Respiratory
Event
DetectionOSA detection
Hypopnea detection
Snore detectionOSA detection
Hypopnea detection
Snore detectionOSA detection
Hypopnea detection
Snore detectionIdentical to primary
predicate
Physical Characteristics
Subject DevicePrimary Predicate DeviceSecondary Predicate DeviceComparison
Auto CPAP System
(K211155)Luna® CPAP and Auto
CPAP System
(K153387)Menai System
(K160836)
IEC 60601
ClassificationClass II, Type BFClass II, Type BFClass II, Type BFIdentical to primary
predicate
Degree of
Protection
Against Water
IngressIP22IP22IP22Identical to primary
predicate
Sound Pressure
Level